Literature DB >> 4137590

Contrast media as histamine liberators in man.

G Seidel, G Groppe, C Meyer-Burgdorff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4137590     DOI: 10.1007/bf01970254

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


× No keyword cloud information.
  67 in total

1.  The effects of muscle relaxants other than muscular relaxation.

Authors:  W D PATON
Journal:  Anesthesiology       Date:  1959 Jul-Aug       Impact factor: 7.892

2.  [SIDE EFFECTS AND VALUE OF PRELIMINARY TESTS IN THE USE OF CONTRAST MEDIA].

Authors:  H OESER; V TAENZER
Journal:  Radiologe       Date:  1965-05       Impact factor: 0.635

3.  The influence of different contrast media for cholegraphy on blood pressure and pulse rate.

Authors:  G F SALTZMAN; K A SUNDSTROM
Journal:  Acta radiol       Date:  1960-11       Impact factor: 1.990

4.  A method for the fluorometric assay of histamine in tissues.

Authors:  P A SHORE; A BURKHALTER; V H COHN
Journal:  J Pharmacol Exp Ther       Date:  1959-11       Impact factor: 4.030

5.  The development of organic iodine compounds as x-ray contrast media.

Authors:  V H WALLINGFORD
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1953-12

Review 6.  The release and fate of vaso-active hormones in the circulation.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

7.  [Infusion cholangiography. Pharmacokinetic and clinical findings].

Authors:  H J Herms; H Witt; K Hemsendorf
Journal:  Fortschr Geb Rontgenstr Nuklearmed       Date:  1969-08

8.  [Bilivistan in healthy persons and in liver patients].

Authors:  D Thelen
Journal:  Med Klin       Date:  1967-08

9.  Histamine release in man by propanidid (Epontol), gelatin (Haemaccel), histalog, pentagastrin and insulin.

Authors:  W Lorenz; A Doenicke; G Feifel; K Messmer; R Meier; L Bennesch; H Barth; J Kusche; M Hutzel; E Werle
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

10.  [Urography with triiodide contrast media; comparative studies with urografin (76 o/o), triopac-400 and tri-abrodil (70 o/o)].

Authors:  E SCHMIEDT; K F ALBRECHT; P KOLLE; H H LUBINUS
Journal:  Munch Med Wochenschr       Date:  1957-11-08
View more
  8 in total

Review 1.  Reactions to radiocontrast material. Anaphylactoid events in radiology.

Authors:  P L Lieberman; R L Seigle
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 2.  Anaphylactoid reactions to radiocontrast material.

Authors:  P Lieberman
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

Review 3.  Radiocontrast reactions.

Authors:  P Lieberman; R L Siegle; G Treadwell
Journal:  Clin Rev Allergy       Date:  1986-05

4.  Increased in vitro histamine release by radiographic contrast media in patients with history of incompatibility.

Authors:  J Ring; R A Simon; C M Arroyave
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

5.  Definition and classification of the histamine-release response to drugs in anaesthesia and surgery: studies in the conscious human subject.

Authors:  W Lorenz; A Doenicke; B Schöning; C Ohmann; B Grote; E Neugebauer
Journal:  Klin Wochenschr       Date:  1982-09-01

6.  Evaluation of histamine elimination curves in plasma and whole blood of several circulatory regions: a method for studying kinetics of histamine release in the whole animal.

Authors:  W Lorenz; M Thermann; K Messmer; A Schmall; P Dormann; J Kusche; H Barth; R Tauber; M Hutzel; G Mann; R Uhlig
Journal:  Agents Actions       Date:  1974-12

7.  Human blood cells ultrastructural changes and mediator release after exposure to roentgenographic contrast media.

Authors:  M J Fritzler; J Ring; C M Arroyave; E M Tan
Journal:  Can Med Assoc J       Date:  1978-10-21       Impact factor: 8.262

8.  In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and -independent release reaction and changes in ultrastructure of human blood cells.

Authors:  J Ring; C M Arroyave; M J Frizler; E M Tan
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.